Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The LENS Study: Efficacy and Safety of Lemborexant for Patients With Nocturia
NCT07840638Phase 4Not yet recruiting
- Sponsor
- University of Alberta
- Start
- Oct 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
A Phase 4 trial of lemborexant in nocturia, sponsored by University of Alberta. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT07840638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07840638.